UA78310C2 - Method for preparing quinolin derivatives - Google Patents

Method for preparing quinolin derivatives

Info

Publication number
UA78310C2
UA78310C2 UA20041109639A UA20041109639A UA78310C2 UA 78310 C2 UA78310 C2 UA 78310C2 UA 20041109639 A UA20041109639 A UA 20041109639A UA 20041109639 A UA20041109639 A UA 20041109639A UA 78310 C2 UA78310 C2 UA 78310C2
Authority
UA
Ukraine
Prior art keywords
formula
preparing
quinolin derivatives
derivatives
preparing quinolin
Prior art date
Application number
UA20041109639A
Other languages
English (en)
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Publication of UA78310C2 publication Critical patent/UA78310C2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
UA20041109639A 2002-06-12 2003-05-14 Method for preparing quinolin derivatives UA78310C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0201778A SE0201778D0 (sv) 2002-06-12 2002-06-12 Process for the manufacture of quinoline derivatives
PCT/SE2003/000780 WO2003106424A1 (en) 2002-06-12 2003-05-14 Process for the manufacture of quinoline derivatives

Publications (1)

Publication Number Publication Date
UA78310C2 true UA78310C2 (en) 2007-03-15

Family

ID=20288148

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20041109639A UA78310C2 (en) 2002-06-12 2003-05-14 Method for preparing quinolin derivatives

Country Status (28)

Country Link
EP (1) EP1511732B9 (xx)
JP (1) JP4584709B2 (xx)
KR (1) KR100979216B1 (xx)
CN (1) CN100418950C (xx)
AT (1) ATE348814T1 (xx)
AU (1) AU2003228195B2 (xx)
BR (1) BR0311674A (xx)
CA (1) CA2487329C (xx)
CY (1) CY1107555T1 (xx)
DE (1) DE60310554T2 (xx)
DK (1) DK1511732T5 (xx)
ES (1) ES2278160T3 (xx)
HR (1) HRP20050028B1 (xx)
IL (1) IL165155A (xx)
IS (1) IS2975B (xx)
ME (1) ME00435B (xx)
MX (1) MXPA04012276A (xx)
NO (1) NO329162B1 (xx)
NZ (1) NZ536768A (xx)
PL (1) PL210259B1 (xx)
PT (1) PT1511732E (xx)
RS (1) RS51021B (xx)
RU (1) RU2291861C2 (xx)
SE (1) SE0201778D0 (xx)
SI (1) SI1511732T1 (xx)
UA (1) UA78310C2 (xx)
WO (1) WO2003106424A1 (xx)
ZA (1) ZA200409430B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314124B2 (en) 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
SE0400235D0 (sv) 2004-02-06 2004-02-06 Active Biotech Ab New composition containing quinoline compounds
UA92761C2 (ru) * 2005-10-19 2010-12-10 Тева Фармасьютикл Индастриз, Лтд. Кристаллы лаквинимода натрия и способ их изготовления
AU2007258366B2 (en) * 2006-06-12 2012-10-25 Active Biotech, Ab Stable laquinimod preparations
US8030518B2 (en) 2006-11-28 2011-10-04 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
SI2234485T1 (sl) 2007-12-20 2014-03-31 Teva Pharmaceutical Industries Ltd. Stabilni lakvinimodni pripravki
EA021227B1 (ru) 2008-09-03 2015-05-29 Тева Фармасьютикал Индастриз Лтд. 2-оксо-1,2-дигидрохинолиновые модуляторы иммунной функции
EP2376456A2 (en) * 2008-12-17 2011-10-19 Actavis Group Ptc Ehf Highly pure laquinimod or a pharmaceutically acceptable salt thereof
DE102010048788A1 (de) 2009-02-13 2011-05-19 Amw Gmbh Transdermales System mit Immunmodulator
DE102009008851A1 (de) 2009-02-13 2010-08-19 Amw Gmbh Transdermales System mit Immunmodulator
ES2564931T3 (es) 2009-07-30 2016-03-30 Teva Pharmaceutical Industries Ltd. Tratamiento de enfermedad de Crohn con laquinimod
DK2467372T3 (en) 2009-08-10 2016-08-22 Teva Pharma TREATMENT OF BDNF-RELATED DISEASES USING LAQUINIMOD
DE102010026879A1 (de) 2010-02-11 2011-08-11 AMW GmbH, 83627 Transdermales System mit Immunmodulator
PT2542079E (pt) 2010-03-03 2014-07-18 Teva Pharma Tratamento da artrite reumatoide com uma combinação de laquinimod e metotrexato
PE20130613A1 (es) 2010-03-03 2013-06-23 Teva Pharma Tratamiento de lupus nefritis usando laquinimod
ES2563208T3 (es) * 2010-07-09 2016-03-11 Active Biotech Ab Método para fabricar quinolina-3-carboxamidas
US20120010239A1 (en) * 2010-07-09 2012-01-12 Ulf Tomas Fristedt 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof
KR20130092558A (ko) 2010-07-09 2013-08-20 테바 파마슈티컬 인더스트리즈 리미티드 중수소화된 n-에틸-n-페닐-1,2-다이하이드로-4-하이드록시-5-클로로-1-메틸-2-옥소퀴놀린-3-카복스아마이드, 그의 염 및 용도
EP2537517A1 (en) * 2011-06-22 2012-12-26 Active Biotech AB Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
US8889627B2 (en) 2011-10-12 2014-11-18 Teva Pharmaceutical Industries, Ltd. Treatment of multiple sclerosis with combination of laquinimod and fingolimod
WO2013116657A1 (en) 2012-02-03 2013-08-08 Teva Pharmaceutical Industries Ltd. USE OF LAQUINIMOD FOR TREATING CROHN'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNFα THERAPY
US9284276B2 (en) 2012-02-16 2016-03-15 Teva Pharmaceutical Industries, Ltd. N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof
TW201350467A (zh) 2012-05-08 2013-12-16 Teva Pharma Ｎ－乙基－４－羥基－１－甲基－５－（甲基（２，３，４，５，６－五羥基己基）胺基）－２－側氧－ｎ－苯基－１，２－二氫喹啉－３－甲醯胺
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
TW201410244A (zh) 2012-08-13 2014-03-16 Teva Pharma 用於治療ｇａｂａ媒介之疾病之拉喹莫德（ｌａｑｕｉｎｉｍｏｄ）
CN103626701A (zh) * 2012-08-28 2014-03-12 天津药物研究院 一种制备喹啉衍生物的方法
CN103626702A (zh) * 2012-08-30 2014-03-12 天津药物研究院 一种制备喹啉酮衍生物的方法
MX2015005632A (es) 2012-11-07 2016-02-05 Teva Pharma Sales de amina de laquinimod.
NZ630427A (en) 2013-03-14 2017-06-30 Teva Pharma Crystals of laquinimod sodium and improved process for the manufacture thereof
AU2015253330A1 (en) 2014-04-29 2016-12-01 Teva Pharmaceutical Industries Ltd. Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients with a high disability status
KR102533033B1 (ko) 2014-09-23 2023-05-15 액티브 바이오테크 에이비 다발성 골수종의 치료에 사용하기 위한 퀴놀린 카르복사미드
MX2017006110A (es) 2014-11-19 2017-07-27 Active Biotech Ab Carboxamidas de quinolina para usarse en el tratamiento de leucemia.
MX2022010327A (es) 2020-03-03 2022-11-09 Active Biotech Ab Tasquinimod o una sal farmaceuticamente aceptable del mismo para el uso en una terapia combinada.
CN111732540B (zh) * 2020-07-20 2020-11-13 湖南速博生物技术有限公司 一种罗喹美克的制备方法
CA3185531A1 (en) 2020-07-23 2022-01-27 Rebekka Katharina Marita SCHNEIDER-KRAMANN S100 proteins as novel therapeutic targets in myeloproliferative neoplasms
US20240091215A1 (en) 2021-01-18 2024-03-21 Active Biotech Ab Tasquinimod or a pharmaceutically acceptable salt thereof for use in the treatment of myelodysplastic syndrome
CA3218977A1 (en) 2021-05-25 2022-12-01 Hans Wannman A plurality of tasquinimod particles and use thereof
IL309486A (en) 2021-07-02 2024-02-01 Active Biotech Ab A pharmacy product containing tesquinimod and a method for evaluating the cleanliness of this product

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
US6077851A (en) * 1998-04-27 2000-06-20 Active Biotech Ab Quinoline derivatives
SE9801474D0 (sv) * 1998-04-27 1998-04-27 Active Biotech Ab Quinoline Derivatives
SE9802550D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
US6121287A (en) * 1998-07-15 2000-09-19 Active Biotech Ab Quinoline derivatives

Also Published As

Publication number Publication date
CA2487329A1 (en) 2003-12-24
AU2003228195B2 (en) 2009-05-28
RS51021B (sr) 2010-10-31
IS2975B (is) 2017-07-15
IL165155A (en) 2009-11-18
RU2005100054A (ru) 2005-07-10
RU2291861C2 (ru) 2007-01-20
ZA200409430B (en) 2006-02-22
CN100418950C (zh) 2008-09-17
SE0201778D0 (sv) 2002-06-12
SI1511732T1 (sl) 2007-06-30
WO2003106424A1 (en) 2003-12-24
CA2487329C (en) 2010-11-16
ES2278160T3 (es) 2007-08-01
IL165155A0 (en) 2005-12-18
EP1511732A1 (en) 2005-03-09
ME00435B (me) 2011-10-10
JP2005535612A (ja) 2005-11-24
DK1511732T3 (da) 2007-04-30
ATE348814T1 (de) 2007-01-15
DK1511732T5 (da) 2007-10-01
CY1107555T1 (el) 2013-03-13
NZ536768A (en) 2006-10-27
NO329162B1 (no) 2010-08-30
AU2003228195A1 (en) 2003-12-31
DE60310554T2 (de) 2007-11-29
PL210259B1 (pl) 2011-12-30
HRP20050028A2 (en) 2006-02-28
PL373817A1 (en) 2005-09-19
KR100979216B1 (ko) 2010-08-31
KR20050016537A (ko) 2005-02-21
EP1511732B9 (en) 2008-11-12
MXPA04012276A (es) 2005-04-08
PT1511732E (pt) 2007-03-30
DE60310554D1 (de) 2007-02-01
CN1659146A (zh) 2005-08-24
EP1511732B1 (en) 2006-12-20
BR0311674A (pt) 2008-01-08
HRP20050028B1 (hr) 2013-07-31
JP4584709B2 (ja) 2010-11-24
IS7550A (is) 2004-11-24
RS107604A (xx) 2007-02-05
NO20045703L (no) 2004-12-29

Similar Documents

Publication Publication Date Title
UA78310C2 (en) Method for preparing quinolin derivatives
NO20055099L (no) Fremgangsmate for fremstilling av 5-(haloacetyl)-8-(substituert oksy)-(1H)-kinolin-2-oner
HUP0301699A2 (hu) Imidazolil-anilin-származékok előállítása anilinek és azolok racionális ligandum-gyorsított Ullmann-kapcsolásával
RS65604A (xx) Novi estri fluorenkarbonske kiseline, postupak za njihovo pripremanje, kao i njihova upotreba kao lekova
NO20051047L (no) Fremgangsmate og mellomprodukter for fremstilling av tienopyrrolderivater
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
WO2004052891A8 (fr) Composes heterocyclique, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
EP1787983A4 (en) PROCESS FOR THE PREPARATION OF ISOINDOL DERIVATIVES
NZ236293A (en) 1-(alkyl or alkoxyalkyl)-4-phenyl piperidine-4-carboxylic acid amide derivatives; preparatory processes and pharmaceutical compositions
NO20055924L (no) Metode for fremstilling av (2s)-3-(4- {2-[Amino]-2-Oksoetoksy}Fenyl)-2-Etoksypropansyrederivater
WO2004091627A3 (en) Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
WO2003024913A1 (fr) Derives d'acides benzoiques substitues possedant une activite d'inhibition de nf-kb
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
EE05136B1 (et) Asendatud imidasopridiinhendite valmistamise meetod
MXPA04008694A (es) Proceso para fabricar composiciones de pigmento de perileno.
WO2003014094A3 (de) Heterocyclylarylsulfonamide
GEP20084296B (en) Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
HUP0203421A2 (hu) Eljárás 10,11-metanobenzoszuberán-származékok előállítására, valamint a közbenső termékként alkalmazott vegyületek és ezek előállítására szolgáló eljárások
AU2003229729A1 (en) A process for the preparation of benazepril hydrochloride
TW200505911A (en) Crystal of benzimidazole derivative and process for producing the same
IN2012DN02301A (xx)
WO2009101432A3 (en) Process for preparing pyridone derivatives
EP1142892A4 (en) METHOD FOR PRODUCING NEW NAPHTYRIDINE DERIVATIVES
ES2184633A1 (es) Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
RU2003124060A (ru) Производные индолина и способ их получения